Andera Partners

Andera Partners is a prominent French private equity firm headquartered in Paris, boasting a diverse investment strategy across several distinct franchises. With over €4 billion (approximately $4.3 billion) in assets under management, the firm engages in various stages of private equity, including growth equity, small-cap buyouts, mid-cap buyouts, infrastructure, and particularly, venture capital within the life sciences sector. This multi-strategy approach allows Andera Partners to support companies across different growth phases and industries, from nascent startups to mature businesses.

The firm's venture capital arm, Andera Life Sciences, is particularly focused on early- and late-stage investments in the healthcare and biotechnology sectors. Through its BioDiscovery funds, Andera Life Sciences targets innovative companies developing new therapies, medical devices, and digital health solutions. Their investment philosophy emphasizes long-term partnerships with management teams, providing not only capital but also strategic guidance and operational support to foster significant growth and market leadership.

For its venture investments, Andera Life Sciences typically deploys initial cheques ranging from €3 million to €20 million (approximately $3.24 million to $21.6 million), with the capacity to invest up to €50 million over a company's lifecycle. Since its inception, Andera Life Sciences has demonstrated a strong track record, having supported over 80 companies, contributing significantly to the European life sciences ecosystem. The firm's commitment to fostering innovation and its deep industry expertise make it a key player in the European venture capital landscape, particularly for ambitious life sciences ventures.